Topic

Prolastin-C (alpha1-proteinase inhibitor)

A collection of 37 issues

How to Get Prolastin-C Covered by Cigna in Georgia: Prior Authorization, Appeals, and Cost-Saving Strategies

Answer Box: Getting Prolastin-C Covered by Cigna in Georgia Cigna requires prior authorization for Prolastin-C with documented alpha1-antitrypsin deficiency (AAT <80 mg/dL) and baseline pulmonary function tests. Submit PA via CoverMyMeds or provider portal with genotype confirmation and clinical notes. If denied, you have 180 days for internal

How to Get Prolastin-C Covered by Blue Cross Blue Shield in Florida: Complete Prior Authorization and Appeals Guide

Quick Answer: Getting Prolastin-C Approved by Florida Blue Cross Blue Shield To get Prolastin-C covered by Blue Cross Blue Shield in Florida, you need prior authorization showing severe alpha-1 antitrypsin deficiency (AAT level <57 mg/dL, Pi*ZZ genotype), emphysema with FEV1 25-80% predicted, and proper ICD-10 coding (E88.

Aetna (CVS Health) Coverage Criteria for Prolastin-C in Florida: What Counts as "Medically Necessary"?

Answer Box To get Prolastin-C covered by Aetna (CVS Health) in Florida, you need: 1) Confirmed severe AAT deficiency (Pi*ZZ genotype + serum AAT <57 mg/dL), 2) Post-bronchodilator FEV₁ between 25-80% predicted, and 3) Documentation of emphysema/COPD due to AAT deficiency. Submit prior authorization using Aetna'

How to Get Prolastin-C (Alpha1-Proteinase Inhibitor) Covered by Aetna CVS Health in Michigan: Complete Coding, Prior Authorization & Appeals Guide

Answer Box: Getting Prolastin-C Covered by Aetna CVS Health in Michigan Prolastin-C requires prior authorization from Aetna CVS Health with specific coding and documentation. Use ICD-10 code E88.01 (alpha-1 antitrypsin deficiency) with J43.9 (emphysema), HCPCS code J0256 (10mg units), and NDC 13533-0700-xx series. Submit PA forms to 888-267-3277

Renewing Prolastin-C Coverage with Cigna in Pennsylvania: Complete 2025 Guide to Authorization, Appeals, and Timing

Answer Box: Fastest Path to Prolastin-C Renewal Cigna requires annual reauthorization for Prolastin-C in Pennsylvania. Start your renewal 60-90 days before expiration by gathering updated spirometry (within 6 months), recent clinical notes from your pulmonologist, and documentation of continued clinical benefit. Submit via your provider's Cigna portal or

How to Get Prolastin-C (Alpha1-Proteinase Inhibitor) Covered by Cigna in Michigan: Complete PA Guide and Appeals Process

Answer Box: Getting Prolastin-C Covered by Cigna in Michigan Cigna requires prior authorization for Prolastin-C (alpha1-proteinase inhibitor) with step therapy preference over Zemaira. Key requirements: severe AAT deficiency (genotype Pi*ZZ or equivalent), serum AAT <80 mg/dL, emphysema documentation, and non-smoker status. First step today: Have your pulmonologist

Myths vs. Facts: Getting Prolastin-C Covered by UnitedHealthcare in Florida (2025 Guide)

Answer Box: Prolastin-C Coverage by UnitedHealthcare in Florida UnitedHealthcare requires prior authorization for Prolastin-C with documented severe alpha-1 antitrypsin deficiency (Pi*ZZ genotype), emphysema evidence, and step therapy trial of preferred alternatives like Aralast NP or Glassia unless contraindicated. Coverage falls under medical benefit with site-of-care preference for home infusion

Do You Qualify for Prolastin-C Coverage by Blue Cross Blue Shield in Georgia? Decision Tree & Next Steps

Answer Box: Getting Prolastin-C Covered in Georgia Most likely to get approved: Adults with confirmed severe alpha-1 antitrypsin deficiency (Pi*ZZ genotype, AAT level ≤11 µM), emphysema on imaging, non-smoking status, and documented optimal COPD therapy. Blue Cross Blue Shield Georgia typically requires prior authorization through their specialty pharmacy program.

How to Get Prolastin-C Covered by Aetna in New York: Complete Prior Authorization and Appeal Guide

Answer Box: Getting Prolastin-C Covered by Aetna in New York Prolastin-C requires prior authorization from Aetna in New York. To get approved: (1) Have your pulmonologist complete Aetna's Alpha-1 Proteinase Inhibitors PA form with severe genotype (Pi*ZZ), FEV1 30-65% predicted, and non-smoking status, (2) Submit via phone

Renewing Prolastin-C (Alpha1-Proteinase Inhibitor) Approval with Aetna CVS Health in Washington: Timeline, Documentation & Appeal Guide

Answer Box: Renewing Prolastin-C Coverage with Aetna CVS Health Start your renewal 90 days early. Aetna typically approves Prolastin-C for 3-6 months initially, then 12-month renewals. You'll need updated AAT levels, FEV1 results, and proof of clinical benefit. Submit 60 days before expiration through CVS Caremark or your